✦ LIBER ✦

Long-term efficacy of entecavir therapy in chronic hepatitis B patients with antiviral resistance to lamivudine and adefovir

✍ Scribed by M. S. Kwak; J. W. Choi; J. S. Lee; K. A. Kim; J. H. Suh; Y. S. Cho; S. Y. Won; B. K. Park; C. K. Lee

Book ID: 108886604
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 138 KB
Volume: 18
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2011.01461.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy of entecavir in adefo

Long-term efficacy of entecavir in adefovir-refractory chronic hepatitis B patients with prior lamivudine resistance

✍ J. W. Park; H. S. Kim; D. D. Seo; J. S. Jang; W. G. Shin; K. H. Kim; M. K. Jang; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Antiviral efficacy of combination therap

Antiviral efficacy of combination therapy with entecavir and adefovir for entecavir/lamivudine-resistant hepatitis B virus with or without adefovir resistance

✍ Hyo-Joon Yang; Jeong-Hoon Lee; Yoon Jun Kim; Jung-Hwan Yoon; Hyo-Suk Lee 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

## Abstract There is little clinical information on the management of hepatitis B virus (HBV) that is resistant to multiple drugs including entecavir (ETV). The present retrospective cohort study assessed the antiviral efficacy of ETV/adefovir dipivoxil (ADV) combination therapy for ETV‐resistant H

Efficacy of entecavir in patients with c

Efficacy of entecavir in patients with chronic hepatitis B resistant to both lamivudine and adefovir or to lamivudine alone

✍ Ju Hyun Shim; Dong Jin Suh; Kang Mo Kim; Young-Suk Lim; Han Chu Lee; Young-Hwa C 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB 👁 1 views

Entecavir (ETV) is currently recommended as a rescue therapy purely for adefovir (ADV)resistant chronic hepatitis B virus (HBV) infections. We evaluated the efficacy of ETV in patients who were resistant to lamivudine (LAM)/ADV sequential therapy and in those resistant to LAM monotherapy. Fifty LAM/

Low efficacy of entecavir therapy in ade

Low efficacy of entecavir therapy in adefovir-refractory hepatitis B patients with prior lamivudine resistance

✍ S. W. Cho; K. H. Koh; J. Y. Cheong; M. H. Lee; S. P. Hong; W. D. Yoo; S.-O. Kim 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Efficacy of adefovir add-on lamivudine r

Efficacy of adefovir add-on lamivudine rescue therapy compared with switching to entecavir monotherapy in patients with lamivudine-resistant chronic hepatitis B

✍ Han Jak Ryu; Jung Min Lee; Sang Hoon Ahn; Do Young Kim; Myoung Ha Lee; Kwang-Hyu 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 1 views

## Abstract No study has reported on the comparative effect of adefovir (ADV) add‐on lamivudine (LAM) versus switching to entecavir (ETV) in LAM‐resistant patients with chronic hepatitis B. From October 2007 to September 2008, 92 consecutive LAM‐resistant patients were enrolled (47 LAM + ADV and 45

Adefovir-based combination therapy with

Adefovir-based combination therapy with entecavir or lamivudine for patients with entecavir-refractory chronic hepatitis B

✍ Soon Sun Kim; Jae Youn Cheong; Dami Lee; Myoung Hee Lee; Sun Pyo Hong; Soo-Ok Ki 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 160 KB

This study evaluated the efficacy of adefovir (ADV) plus lamivudine (LAM) or ADV add-on therapy for patients with entecavir (ETV)-refractory hepatitis B infection. Twenty-nine ETVresistant and 8 patients with suboptimal response to ETV were enrolled. Twenty-seven patients received ADV þ LAM therapy